Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells

Metformin (MET) is increasingly implicated in reducing the incidence of multiple cancer types in patients with diabetes. However, similar effects of MET in non-diabetic women with endometrial cancer (EC) remain unknown. In a pilot study, obese non-diabetic women diagnosed with type 1, grade 1/2 EC,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Reprod Sci
Main Authors: Pabona, John Mark P, Burnett, Alexander F, Brown, Dustin M, Quick, Charles M, Simmen, Frank A, Montales, Maria Theresa E, Liu, Shi J, Rose, Tyler, Alhallak, Iad, Siegel, Eric R, Simmen, Rosalia CM
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7077930/
https://ncbi.nlm.nih.gov/pubmed/32046384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s43032-019-00019-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados